Quarterly report [Sections 13 or 15(d)]

Stock Based Compensation (Tables)

v3.25.3
Stock Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity under our equity compensation plans:

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate Intrinsic Value ('000)

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding as of December 31, 2024

 

 

1,978,557

 

 

$

16.72

 

 

 

4.5

 

 

 

 

Granted

 

 

21,650

 

 

$

11.00

 

 

 

 

 

 

 

Exercised

 

 

(241,132

)

 

$

7.57

 

 

 

 

 

 

 

Forfeited, canceled, or expired

 

 

(146,090

)

 

$

18.96

 

 

 

 

 

 

 

Options outstanding as of September 30, 2025

 

 

1,612,985

 

 

$

17.81

 

 

 

4.3

 

 

$

561

 

Vested and expected to vest at September 30, 2025

 

 

1,612,985

 

 

$

17.81

 

 

 

4.3

 

 

$

561

 

Exercisable at September 30, 2025

 

 

1,591,335

 

 

$

17.91

 

 

 

4.2

 

 

$

561

 
Summary of Restricted Stock Units Activity

The following table summarizes restricted stock unit (“RSU”) activity under the 2021 Plan:

 

 

 

 

Number of RSUs

 

 

Weighted Average Grant Date Fair Value per Share

 

Outstanding as of December 31, 2024

 

 

 

 

2,777,156

 

 

$

10.32

 

RSUs granted

 

 

 

 

1,470,585

 

 

$

11.68

 

RSUs and PSUs vested

 

 

 

 

(1,195,091

)

 

$

11.49

 

RSUs forfeited

 

 

 

 

(584,055

)

 

$

9.97

 

Outstanding as of September 30, 2025

 

 

 

 

2,468,595

 

 

$

10.65

 
Schedule of Stock Based Compensation Expense Based on Roles and Responsibilities of Employees

The following table summarizes the components of total stock-based compensation expense based on roles and responsibilities of the employees within the condensed consolidated statements of operations:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

62

 

 

$

58

 

 

$

254

 

 

$

182

 

Research and development

 

 

747

 

 

 

1,180

 

 

 

2,409

 

 

 

3,408

 

Sales and marketing

 

 

219

 

 

 

893

 

 

 

2,187

 

 

 

2,512

 

General and administrative

 

 

2,802

 

 

 

2,828

 

 

 

10,107

 

 

 

7,280

 

 

$

3,830

 

 

$

4,959

 

 

$

14,957

 

 

$

13,382